Shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven research firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, four have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $104.25.
Several equities analysts have commented on the company. Barrington Research increased their target price on U.S. Physical Therapy from $110.00 to $122.00 and gave the company an "outperform" rating in a research report on Friday, November 13th. Weiss Ratings restated a "hold (c-)" rating on shares of U.S. Physical Therapy in a report on Wednesday, August 26th. JPMorgan Chase & Co. upped their price objective on U.S. Physical Therapy from $90.00 to $95.00 and gave the company an "overweight" rating in a research note on Friday, September 11th. Finally, Citigroup reiterated a "market outperform" rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th.
View Our Latest Stock Analysis on U.S. Physical Therapy
U.S. Physical Therapy Stock Performance
NYSE USPH opened at $97.48 on Wednesday. The firm's fifty day moving average price is $87.10 and its two-hundred day moving average price is $77.55. The stock has a market cap of $1.46 billion, a PE ratio of -72.21, a PEG ratio of 2.73 and a beta of 1.16. U.S. Physical Therapy has a fifty-two week low of $58.19 and a fifty-two week high of $101.80. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.42 and a current ratio of 1.42.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Thursday, November 5th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.76 by $0.04. The company had revenue of $222.56 million for the quarter, compared to the consensus estimate of $214.48 million. U.S. Physical Therapy had a return on equity of 10.19% and a net margin of 3.60%. U.S. Physical Therapy's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter last year, the business posted $0.66 EPS. On average, equities analysts expect that U.S. Physical Therapy will post 2.87 EPS for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 11th. Shareholders of record on Monday, November 16th will be given a $0.46 dividend. This represents a $1.84 annualized dividend and a yield of 1.9%. The ex-dividend date is Monday, November 16th. U.S. Physical Therapy's dividend payout ratio is -136.30%.
Hedge Funds Weigh In On U.S. Physical Therapy
Several large investors have recently modified their holdings of USPH. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new stake in shares of U.S. Physical Therapy during the second quarter worth $30,000. Allworth Financial LP raised its stake in U.S. Physical Therapy by 1,341.7% during the third quarter. Allworth Financial LP now owns 346 shares of the company's stock worth $30,000 after buying an additional 322 shares during the last quarter. Integrated Wealth Concepts LLC bought a new position in U.S. Physical Therapy during the second quarter worth $33,000. Fulcrum Asset Management LLP acquired a new position in U.S. Physical Therapy in the third quarter valued at $35,000. Finally, Sterling Capital Management LLC lifted its holdings in U.S. Physical Therapy by 221.0% in the third quarter. Sterling Capital Management LLC now owns 443 shares of the company's stock valued at $38,000 after buying an additional 305 shares during the period.
About U.S. Physical Therapy
(
Get Free Report)
U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics across the United States. Its clinics provide rehabilitation for musculoskeletal conditions, orthopedic injuries, sports-related injuries and recovery following surgery, along with other therapy services tailored to patients' needs. Founded in 1990 and headquartered in Houston, Texas, the company also provides industrial injury prevention and related services to employers. Its clinic network serves communities in multiple states, with care delivered through local therapy practices.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider U.S. Physical Therapy, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.
While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.